Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amkocid DS SF Syrup is an Ayurvedic proprietary medicine developed and marketed by Amogh Pharmaceuticals. The formulation is characterized as a double-strength (DS), sugar-free (SF) syrup, making it suitable for diabetic patients or individuals monitoring their sugar intake. It is primarily indicated for the management of gastrointestinal conditions such as hyperacidity, heartburn, gastritis, and peptic ulcers. The syrup acts as a natural antacid, utilizing traditional Ayurvedic ingredients like Yashtimadhu (Glycyrrhiza glabra) and Shatavari (Asparagus racemosus) to neutralize excess gastric acid and provide a protective, soothing coating to the esophageal and gastric mucosa. This cytoprotective effect helps in the healing of ulcers and reduces inflammation associated with acid reflux and dyspepsia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amkocid DS SF Syrup.